Conduit Pharmaceuticals Stock Filter Stocks by Fundamentals
CDT Stock | 0.11 0.01 11.00% |
Conduit Pharmaceuticals fundamentals help investors to digest information that contributes to Conduit Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Conduit Stock. The fundamental analysis module provides a way to measure Conduit Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Conduit Pharmaceuticals stock.
Conduit |
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Conduit Fundamentals
Return On Asset | -3.22 | ||||
Current Valuation | 14.98 M | ||||
Shares Outstanding | 116.8 M | ||||
Shares Owned By Insiders | 49.11 % | ||||
Shares Owned By Institutions | 4.05 % | ||||
Number Of Shares Shorted | 2.36 M | ||||
EBITDA | (324 K) | ||||
Net Income | (535 K) | ||||
Total Debt | 985 K | ||||
Book Value Per Share | (0.01) X | ||||
Cash Flow From Operations | (7.72 M) | ||||
Short Ratio | 0.14 X | ||||
Earnings Per Share | (0.23) X | ||||
Beta | 2.12 | ||||
Market Capitalization | 12.46 M | ||||
Total Asset | 7.22 M | ||||
Retained Earnings | (11.3 M) | ||||
Working Capital | 3.93 M | ||||
Net Asset | 7.22 M |
About Conduit Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Conduit Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Conduit Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Conduit Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.